These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17619565)
41. Compliance with guidelines in the treatment of asthma exacerbations in primary care. Flor-Escriche X; Rodríguez-Mas M; Espiau M; Castán-Enseñat X; Vigatà-Reig JM; Poblet-Cortés R; Miravitlles M Ther Adv Respir Dis; 2011 Dec; 5(6):369-75. PubMed ID: 21921074 [TBL] [Abstract][Full Text] [Related]
42. Value of the bronchodilator response in assessing controller naïve asthmatic children. Galant SP; Morphew T; Amaro S; Liao O J Pediatr; 2007 Nov; 151(5):457-62, 462.e1. PubMed ID: 17961685 [TBL] [Abstract][Full Text] [Related]
43. Treatment characteristics in elderly asthmatics. Ekici M; Ekici A; Keles H; Akin A Int J Clin Pract; 2008 May; 62(5):729-34. PubMed ID: 17971157 [TBL] [Abstract][Full Text] [Related]
44. Impact of asthma severity as risk factor to future exacerbations in patients admitted for asthma exacerbation. Nakwan N Multidiscip Respir Med; 2021 Jan; 16(1):780. PubMed ID: 34557299 [TBL] [Abstract][Full Text] [Related]
45. Asthma in adventure travelers: a prospective study evaluating the occurrence and risk factors for acute exacerbations. Golan Y; Onn A; Villa Y; Avidor Y; Kivity S; Berger SA; Shapira I; Levo Y; Giladi M Arch Intern Med; 2002 Nov; 162(21):2421-6. PubMed ID: 12437400 [TBL] [Abstract][Full Text] [Related]
46. [Rate and characteristics of asthma exacerbations: the ASMAB I study]. Morell F; Genover T; Muñoz X; García-Aymerich J; Ferrer J; Cruz MJ Arch Bronconeumol; 2008 Jun; 44(6):303-11. PubMed ID: 18559219 [TBL] [Abstract][Full Text] [Related]
47. Disability and breathlessness in asthmatic patients--a scoring method by repetitive inspiratory effort. Loh LC; Puah SH; Ho CV; Chow CY; Chua CY; Jayaram J; Kavetha C; Wong SJ J Asthma; 2005 Dec; 42(10):853-8. PubMed ID: 16393724 [TBL] [Abstract][Full Text] [Related]
48. Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma. Lane SJ; Petersen H; Seltzer JM; Blanchette CM; Navaratnam P; Allen-Ramey F; Fuhlbrigge A J Asthma; 2013 Aug; 50(6):642-8. PubMed ID: 23514102 [TBL] [Abstract][Full Text] [Related]
49. [Prevalence and characteristics of rhinitis in adult asthmatic patients attending allergist, primary care and pulmonologist settings in Spain (AIR study)]. Castillo JA; Navarro A; Quirce S; Molina J; García-Marcos L; Juliá B; Valero A; Mullol J Med Clin (Barc); 2011 Mar; 136(7):284-9. PubMed ID: 21047654 [TBL] [Abstract][Full Text] [Related]
50. Status of lipid peroxidation and plasma iron level in bronchial asthmatic patients. Narula MK; Ahuja GK; Whig J; Narang AP; Soni RK Indian J Physiol Pharmacol; 2007; 51(3):289-92. PubMed ID: 18341227 [TBL] [Abstract][Full Text] [Related]
51. Characterisation of patients with frequent exacerbation of asthma. Koga T; Oshita Y; Kamimura T; Koga H; Aizawa H Respir Med; 2006 Feb; 100(2):273-8. PubMed ID: 15998585 [TBL] [Abstract][Full Text] [Related]
52. Exercise-induced bronchospasm in children: effects of asthma severity. Cabral AL; Conceição GM; Fonseca-Guedes CH; Martins MA Am J Respir Crit Care Med; 1999 Jun; 159(6):1819-23. PubMed ID: 10351925 [TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma. Ohta K; Miyamoto T; Amagasaki T; Yamamoto M; Respirology; 2009 Nov; 14(8):1156-65. PubMed ID: 19909462 [TBL] [Abstract][Full Text] [Related]
54. Inverse correlation of expiratory lung flows and sputum eosinophils in status asthmaticus. Alfaro C; Sharma OP; Navarro L; Glovsky MM Ann Allergy; 1989 Sep; 63(3):251-4. PubMed ID: 2774309 [TBL] [Abstract][Full Text] [Related]
55. Comparative features of Asthma with frequent or infrequent exacerbations: A longitudinal study of retrospective and prospective events. Boulay MÈ; Pruneau-Pomerleau C; Villeneuve H; Deschesnes F; Ringuette L; Boulet LP J Asthma; 2018 Mar; 55(3):231-243. PubMed ID: 29020468 [TBL] [Abstract][Full Text] [Related]
56. The Prevalence, Characteristics, and Patient Burden of Severe Asthma Determined by Using a Japan Health Care Claims Database. Sato K; Ohno T; Ishii T; Ito C; Kaise T Clin Ther; 2019 Nov; 41(11):2239-2251. PubMed ID: 31629532 [TBL] [Abstract][Full Text] [Related]
57. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry? Melbye H; Al-Ani S; Spigt M Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453 [TBL] [Abstract][Full Text] [Related]
58. Severity of asthma score predicts clinical outcomes in patients with moderate to severe persistent asthma. Eisner MD; Yegin A; Trzaskoma B Chest; 2012 Jan; 141(1):58-65. PubMed ID: 21885725 [TBL] [Abstract][Full Text] [Related]
59. Survey of outcome of asthmatic children referred to outpatient clinic of Tabriz University of Medical Sciences. Nemat B; Ahadi A Pak J Biol Sci; 2008 Jul; 11(14):1860-3. PubMed ID: 18817232 [TBL] [Abstract][Full Text] [Related]
60. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Bousquet J; Cabrera P; Berkman N; Buhl R; Holgate S; Wenzel S; Fox H; Hedgecock S; Blogg M; Cioppa GD Allergy; 2005 Mar; 60(3):302-8. PubMed ID: 15679714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]